Bayban’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-20
Closed -$452 – 583
2026
Q2
$452 Hold
20
– – ﹤0.01% 582
2026
Q1
$500 Hold
20
– – ﹤0.01% 652
2025
Q4
$629 Buy
+20
New +$663 ﹤0.01% 590

Other funds holding PRCT

Bayban's PRCT Position: Q3 2026 in Review

Bayban sold out of Procept Biorobotics (PRCT) in Q3 2026, closing a stake of 20 shares — an estimated $452 sold.

Bayban first reported a position in PRCT in Q4 2025 and held it in 3 quarters. The position peaked at $629 in Q4 2025. 232 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.

  • Bayban reported no remaining Procept Biorobotics position as of Q3 2026 after selling out during the quarter.
  • Bayban sold 20 Procept Biorobotics shares in Q3 2026, an estimated $452.
  • Bayban first reported a position in Procept Biorobotics in Q4 2025 and held it in 3 quarters.
  • Bayban's Procept Biorobotics position peaked at $629 in Q4 2025.
  • 232 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.

Based on Bayban's 13F filing for Q3 2026, filed 5 Nov 2026.